Integra LifeSciences Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Integra LifeSciences Holdings generated cash of $139,955,000, which is less than the previous year. Cash used in financing activities reached the amount of -$229,925,000 last year. Net change in cash is therefore -$180,259,000.
Cash Flow
| 2014 | 79.46M | -363.31M | 242.78M |
|---|---|---|---|
| 2015 | 94.48M | -372.01M | 258.51M |
| 2016 | 116.40M | -42.62M | -15.11M |
| 2017 | 114.54M | -1.22B | 1.16B |
| 2018 | 199.68M | -49.70M | -180.87M |
| 2019 | 373.68M | -304.72M | 64.46M |
| 2020 | 203.83M | -68.07M | 121.62M |
| 2021 | 312.42M | -161.44M | -98.22M |
| 2022 | 264.46M | -58.58M | -251.95M |
| 2023 | 139.95M | -94.17M | -229.92M |
IART Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 456.66M | 513.44M | 470.16M | 198.91M | 138.83M | 174.93M | 102.05M | 48.13M | 71.99M | 120.61M |
Operating activities | ||||||||||
Net income | 67.74M | 180.55M | 169.07M | 133.89M | 50.20M | 60.80M | 64.74M | 74.56M | 6.85M | 34.00M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 123.51M | 118.29M | 119.83M | 116.03M | 109.46M | 110.73M | 88.94M | 72.66M | 58.86M | 61.12M |
Stock-based compensation expense | 20.14M | 27.72M | 36.21M | 19.59M | 21.25M | 0 | 21.55M | 17.31M | 15.45M | 15.10M |
| Deferred income tax benefit | 20.14M | 27.72M | 36.21M | 19.59M | 21.25M | 0 | 21.55M | 17.31M | 15.45M | 15.10M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 4.59M | -33.90M | 7.26M | 52.10M | -9.42M | -17.02M | -89.69M | -17.51M | -16.23M | -16.14M |
Inventories | -59.77M | -29.12M | 5.37M | -48.34M | -43.30M | 8.3M | 99K | -9.57M | -3.75M | -27.00M |
Accounts payable | -20.22M | 17.34M | 32.87M | -57.51M | 14.66M | 3.58M | 95.32M | -414K | 1.62M | 2.42M |
Cash generated by operating activities | 139.95M | 264.46M | 312.42M | 203.83M | 373.68M | 199.68M | 114.54M | 116.40M | 94.48M | 79.46M |
Investing activities | ||||||||||
Purchases Of Investments | -32.69M | -4.90M | -76K | -7.84M | -207.01M | 0 | 293K | 0 | -4.08M | 0 |
Investments In Property Plant And Equipment | -66.86M | -47.08M | -48.08M | -63.89M | -134.53M | -77.74M | -43.50M | -47.32M | -33.41M | -42.39M |
Acquisitions Net | 0 | -27.54M | -113.44M | 3.65M | -30.50M | 26.70M | -1.19B | 225K | -328.88M | -320.92M |
Cash generated by investing activities | -94.17M | -58.58M | -161.44M | -68.07M | -304.72M | -49.70M | -1.22B | -42.62M | -372.01M | -363.31M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 6.82M | 49.79M | 6.94M | 0 | 0 | 10.48M | 219.66M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -275M | -125M | -4.80M | -105.07M | -6.51M | -7.82M | -7.12M | -4.85M | 0 | 0 |
Repayments of term debt | 54.5M | -107.8M | -125.5M | -305.5M | -9.2M | -488.8M | 1.19B | -696.21M | 76.14M | -195.60M |
Cash used in financing activities | -229.92M | -251.95M | -98.22M | 121.62M | 64.46M | -180.87M | 1.16B | -15.11M | 258.51M | 242.78M |
Net Change In Cash | -180.25M | -56.78M | 43.28M | 271.25M | 60.07M | -36.09M | 72.88M | 53.92M | -23.86M | -48.62M |
Cash at end of period | 276.40M | 456.66M | 513.44M | 470.16M | 198.91M | 138.83M | 174.93M | 102.05M | 48.13M | 71.99M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |